STOCK TITAN

Medline's Douglas P. Golwas converts incentive units

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Medline Inc. (MDLN) reported indirect conversion activity and Class B awards associated with Chief Commercial Officer Douglas P. Golwas on November 12, 2026. The report lists dispositions of 948,597 and 463,211 Incentive Units of Medline Holdings, LP, alongside acquisitions of 948,597 and 463,211 Common Units at $15.09 per unit. It also reports 346,901 and 169,395 Common Units delivered or withheld for payment of exercise price or tax liability at $26.67 per unit; a footnote says these units were deemed withheld in connection with the exchange. The footnotes identify Medline Management Aggregator LLC and a trust of which Golwas is trustee in connection with indirect holdings.

The report lists awards of 601,696 Class B shares held directly, with 967,560 following, and 293,816 held indirectly through a trust, with 293,816 following. Medline states its Class B shares have no economic value and one vote per share.

Insider Golwas Douglas P
Role Chief Commercial Officer
Type Security Shares Price Value
Exercise Incentive Units of Medline Holdings, LP F1, F2, F3 948,597 -- --
Exercise Incentive Units of Medline Holdings, LP F1, F2, F3, F4 463,211 -- --
Exercise Common Units of Medline Holdings, LP F5, F1, F2 948,597 $15.09 $14.31M
Exercise Common Units of Medline Holdings, LP F5, F1, F2, F4 463,211 $15.09 $6.99M
Exercise Price or Tax Liability Common Units of Medline Holdings, LP F5, F7, F1, F2 346,901 $26.67 $9.25M
Exercise Price or Tax Liability Common Units of Medline Holdings, LP F5, F7, F1, F2, F4 169,395 $26.67 $4.52M
Grant/Award Class B Common Stock F1, F2, F6 601,696 -- --
Grant/Award Class B Common Stock F1, F2, F6, F4 293,816 -- --
Holdings After Transaction: Incentive Units of Medline Holdings, LP — 0 units (Indirect, See Footnote); Common Units of Medline Holdings, LP — 1,261,376 units (Indirect, See Footnote); Class B Common Stock — 967,560 shares (Direct); Class B Common Stock — 293,816 shares (Indirect, See Footnote)
Footnotes (7)
  1. F1. Reflect incentive units of Medline Holdings, LP ("Incentive Units"), which are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of common units of Medline Holdings, LP ("Common Units") generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Medline Inc.'s (the "Issuer") Class A common stock ("Class A Common Stock")) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.
  2. F2. (Continued from Footnote 1 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC. In connection with the conversion of Incentive Units into Common Units, upon issuance of Common Units, an equivalent number of shares of Class B common stock ("Class B Common Stock") are automatically issued.
  3. F3. These Incentive Units are fully vested.
  4. F4. These securities are held by a trust, of which the Reporting Person is a trustee.
  5. F5. Pursuant to the terms of the Exchange Agreement, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units are held indirectly through Medline Management Aggregator LLC.
  6. F6. Shares of the Issuer's Class B Common Stock have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon the exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock are automatically cancelled.
  7. F7. Reflects Common Units deemed to be withheld in connection with the exchange of Incentive Units described herein.
Incentive Units disposed 948,597 units November 12, 2026
Incentive Units disposed 463,211 units November 12, 2026
Common Units delivered or withheld 346,901 units Reported at $26.67 per unit on November 12, 2026
Common Units delivered or withheld 169,395 units Reported at $26.67 per unit on November 12, 2026
Reported exercise/conversion and Common Unit price $15.09 per unit November 12, 2026
Reported price for Common Units delivered or withheld $26.67 per unit November 12, 2026
Direct Class B share award 601,696 shares November 12, 2026
Indirect Class B share award 293,816 shares Held through a trust; November 12, 2026
profit interests financial
"Incentive Units are “profit interests”"
participation threshold financial
"the per unit participation threshold"
Common Units financial
"Common Units are exchangeable on a one-for-one basis"
Common units are the basic ownership stakes in a company, limited partnership, or trust that function like common stock: they give holders a claim on profits and often voting rights. Think of them as the ordinary seats at a table—the most directly affected by the business’s success or failure, so they typically offer higher upside but carry greater risk than preferred claims or creditors, which matters to investors evaluating potential return and safety.
Exchange Agreement technical
"pursuant to the terms of the Exchange Agreement"
A written deal in which two parties agree to swap assets, securities or obligations under set terms—think of it as a formal swap or trade contract. For investors it matters because such agreements can change who owns what, alter a company’s capital structure, affect future cash flows or dilute existing shares, and therefore influence value and risk in a straightforward, contract-driven way.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions did MDLN Chief Commercial Officer Douglas P. Golwas report on November 12, 2026?

The report lists dispositions of 948,597 and 463,211 Incentive Units and acquisitions of 948,597 and 463,211 Common Units at $15.09 per unit. It also lists 346,901 and 169,395 Common Units delivered or withheld for payment of exercise price or tax liability at $26.67 per unit, and Class B awards of 601,696 shares directly and 293,816 indirectly.

How can Medline Holdings Incentive Units be converted into MDLN shares?

Vested Incentive Units are convertible, at the holder’s election, into a number of Medline Holdings Common Units based generally on the participation threshold and the difference between the Common Unit value and that threshold, subject to adjustments. Common Units are exchangeable one-for-one for Medline Class A common shares, and the exchange rights do not expire.

What rights do MDLN Class B shares carry?

Medline states that Class B shares have one vote per share and no economic value. One Class B share is issued for each Common Unit held, and an equivalent number of Class B shares is automatically cancelled when Common Units are exchanged for Class A shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Golwas Douglas P

(Last)(First)(Middle)
C/O MEDLINE INC.
3 LAKES DRIVE

(Street)
NORTHFIELD ILLINOIS 60093

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Medline Inc. [ MDLN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commercial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class B Common Stock11/12/2026A601,696A(1)(2)(6)967,560D
Class B Common Stock11/12/2026A293,816A(1)(2)(6)293,816ISee Footnote(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Incentive Units of Medline Holdings, LP$15.09(1)(2)11/12/2026M948,597 (1)(2)(3) (1)(2)(3)Class A Common Stock(1)948,597(1)(2)0ISee Footnote(1)(2)
Incentive Units of Medline Holdings, LP$15.09(1)(2)11/12/2026M463,211 (1)(2)(3) (1)(2)(3)Class A Common Stock(1)463,211(1)(2)0ISee Footnote(1)(2)(4)
Common Units of Medline Holdings, LP(5)11/12/2026M948,597 (5) (5)Class A Common Stock948,597$15.09(1)(2)1,314,461ISee Footnote(5)
Common Units of Medline Holdings, LP(5)11/12/2026M463,211 (5) (5)Class A Common Stock463,211$15.09(1)(2)463,211ISee Footnote(4)(5)
Common Units of Medline Holdings, LP(5)11/12/2026F(7)346,901 (5) (5)Class A Common Stock346,901$26.67(1)(2)967,560ISee Footnote(5)
Common Units of Medline Holdings, LP(5)11/12/2026F(7)169,395 (5) (5)Class A Common Stock169,395$26.67(1)(2)293,816ISee Footnote(4)(5)
Explanation of Responses:
1. Reflect incentive units of Medline Holdings, LP ("Incentive Units"), which are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of common units of Medline Holdings, LP ("Common Units") generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Medline Inc.'s (the "Issuer") Class A common stock ("Class A Common Stock")) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.
2. (Continued from Footnote 1 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC. In connection with the conversion of Incentive Units into Common Units, upon issuance of Common Units, an equivalent number of shares of Class B common stock ("Class B Common Stock") are automatically issued.
3. These Incentive Units are fully vested.
4. These securities are held by a trust, of which the Reporting Person is a trustee.
5. Pursuant to the terms of the Exchange Agreement, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units are held indirectly through Medline Management Aggregator LLC.
6. Shares of the Issuer's Class B Common Stock have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon the exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock are automatically cancelled.
7. Reflects Common Units deemed to be withheld in connection with the exchange of Incentive Units described herein.
/s/ Nicole Fritz, Attorney-in-Fact11/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading